The Molecular Biology of Myeloma

David S. Siegel, MD, PhD
Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
April 14, 2015

CancerTREATMENT NGS+ in the Clinic

Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.

September 20, 2013

The Value of Personalized Medicine

John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later